JAG
Journey Advisory Group’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,680
| Closed | -$205K | – | 216 |
|
|
2023
Q3 | $205K | Sell |
1,680
-60
| -3% | -$7.34K | 0.03% | 208 |
|
|
2023
Q2 | $221K | Sell |
1,740
-2,394
| -58% | -$304K | 0.03% | 214 |
|
|
2023
Q1 | $534K | Sell |
4,134
-2,226
| -35% | -$288K | 0.08% | 144 |
|
|
2022
Q4 | $835K | Sell |
6,360
-2,213
| -26% | -$291K | 0.21% | 99 |
|
|
2022
Q3 | $1M | Sell |
8,573
-3,150
| -27% | -$369K | 0.26% | 85 |
|
|
2022
Q2 | $1.43M | Sell |
11,723
-1,765
| -13% | -$216K | 0.33% | 71 |
|
|
2022
Q1 | $1.76M | Sell |
13,488
-279
| -2% | -$36.3K | 0.44% | 57 |
|
|
2021
Q4 | $2.1M | Sell |
13,767
-411
| -3% | -$62.7K | 0.58% | 47 |
|
|
2021
Q3 | $2.29M | Sell |
14,178
-942
| -6% | -$152K | 0.74% | 32 |
|
|
2021
Q2 | $2.47M | Sell |
15,120
-219
| -1% | -$35.8K | 0.79% | 32 |
|
|
2021
Q1 | $2.31M | Buy |
15,339
+444
| +3% | +$66.8K | 0.81% | 32 |
|
|
2020
Q4 | $2.26M | Buy |
+14,895
| New | +$2.26M | 0.84% | 32 |
|